Overview
Paul Armistead is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Armistead is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant. Dr. Armistead is currently accepting new patients.
His clinical research consists of co-authoring 54 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Acute Lymphoblastic Leukemia (ALL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Duke Blood Cancer Center
I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is rated as an Elite provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
University Of North Carolina At Chapel Hill
Katarzyna Jamieson is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Jamieson is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Jamieson is currently accepting new patients.
University Of North Carolina At Chapel Hill
Hendrik Vandeventer is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Vandeventer is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Vandeventer is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without MaturationDr. Armistead isDistinguished. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Armistead isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow TransplantDr. Armistead isDistinguished. Learn about Bone Marrow Transplant.
- Multiple MyelomaDr. Armistead isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Armistead isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Childhood Acute Myeloid LeukemiaDr. Armistead isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- LeukemiaDr. Armistead isAdvanced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Dr. Armistead isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Myelomonocytic LeukemiaDr. Armistead isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult T-Cell LeukemiaDr. Armistead isExperienced. Learn about Adult T-Cell Leukemia.
- Aplastic AnemiaDr. Armistead isExperienced. Learn about Aplastic Anemia.
- Castleman DiseaseDr. Armistead isExperienced. Learn about Castleman Disease.
- Chronic B-Cell Leukemia (CBCL)Dr. Armistead isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Graft Versus Host Disease (cGvHD)Dr. Armistead isExperienced. Learn about Chronic Graft Versus Host Disease (cGvHD).